| FOPAX | OSMNX | FOPAX / OSMNX | |
| Total Expense Ratio | 1.26 | 1.63 | 77% |
| Annual Report Gross Expense Ratio | 1.26 | 1.63 | 77% |
| Fund Existence | 21 years | 25 years | - |
| Gain YTD | 3.474 | 2.780 | 125% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 0 | 1000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 1.63B | 2.56B | 64% |
| Annual Yield % from dividends | 1.72 | 1.26 | 137% |
| Returns for 1 year | 14.76 | -4.35 | -339% |
| Returns for 3 years | 20.19 | -15.32 | -132% |
| Returns for 5 years | -5.67 | -34.89 | 16% |
| Returns for 10 years | 67.26 | 4.80 | 1,401% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| AIOCX | 11.64 | 0.16 | +1.39% |
| American Century International Opps C | |||
| FVILX | 6.30 | 0.07 | +1.12% |
| Forester Value I | |||
| GIRVX | 8.98 | 0.01 | +0.11% |
| Goldman Sachs Intl Eq Div & Prem Inv | |||
| GIEYX | 16.54 | N/A | N/A |
| GuideStone Funds International Eq Instl | |||
| JFNSX | 77.29 | -0.49 | -0.63% |
| Janus Henderson Global Life Sciences S | |||